Loading insider details...
Beta
Latest Form 4 (Aug 31, 2026): Exercise/Conversion of 26,116 JAZZ shares, $2.95M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Exercise/Conversion | 26,116 | $2.95M |
| Jul 13, 2026 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 60,000 | n/a |
| Jul 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 3,764 | $894.8K |
| Jul 1, 2026 | Autolus Therapeutics plc (AUTL) | Grant/Award | 31,667 | n/a |
| Mar 9, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Tax Withholding | 6,209 | $1.17M |
| Mar 2, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 14,822 | n/a |
| Jan 22, 2026 | Jazz Pharmaceuticals plc (JAZZ) | Grant/Award | 11,699 | n/a |
| Nov 20, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 7,159 | $1.20M |
| Mar 12, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Sale | 2,403 | $332.6K |
| Mar 7, 2025 | Jazz Pharmaceuticals plc (JAZZ) | Disposition to Issuer | 5,239 | $728.0K |